ORLANDO, FL—(UPDATED) The Amplatzer Amulet device (Abbott) seals off the left atrial appendage (LAA) better than the Watchman 2.5 or Watchman FLX devices (Boston Scientific) in patients with atrial ...
Bobby Abreu (2009-2012 with LAA, 1998-2006 with PHI) Russell Branyan (2011 with LAA, 2007 with PHI) Matt Joyce (2015 with LAA, 2021 with PHI) Mickey Moniak (2022-2023 with LAA, 2020-2022 with PHI) ...
Credit: Patrick J. Lynch, medical illustrator; C. Carl Jaffe, MD, cardiologist. Adjunctive left atrial appendage (LAA) ligation failed to increase the efficacy of catheter pulmonary vein isolation ...
Please provide your email address to receive an email when new articles are posted on . Abbott announced the FDA approval of its left atrial appendage occlusion device for the treatment of atrial ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Readers were most interested in the results of the SWISS ...
Percutaneously implanted devices designed to seal off the left atrial appendage (LAA) have been around for some time, but a recent study of surgical closure of the appendage might have a beneficial ...
Abbott Laboratories received FDA approval for its Amplatzer Amulet left atrial appendage occluder to treat people with atrial fibrillation who are at risk of ischemic stroke about a month earlier than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback